MedPath

Rinobact P Spray

Brand Name: Rinobact P Spray

Generic Name: Xylometazoline Hydrochloride + Lysozyme Hydrochloride

Active
Registration Number

DRP-12883

Dosage Form

Nasal Spray Solution

Issuance Date

October 25, 2022

Expiry Date

October 25, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength0.5 mg / 0.5 mg per mL
PackagingAmber Glass Bottle with Nasal Spray System and Protective Cap x 10mL

Classification

C
Classification
Over-the-Counter (OTC)
A
Application
Initial (OTC)
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Xylometazoline HydrochlorideActive
Monograph: Xylometazoline
Lysozyme HydrochlorideActive
Monograph: Lysozyme

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform